TY - JOUR
T1 - Role of retinoic acid in the modulation of benzo(a)pyrene-DNA adducts in human hepatoma cells
T2 - Implications for cancer prevention
AU - Zhou, Guo Dong
AU - Richardson, Molly
AU - Fazili, Inayat S.
AU - Wang, Jianbo
AU - Donnelly, Kirby C.
AU - Wang, Fen
AU - Amendt, Brad
AU - Moorthy, Bhagavatula
N1 - Funding Information:
This research work was supported by the National Institute of Health grants ES04917 , ES009132 , ES09106 (National Institute of Environmental Health Sciences), HL070921 and HL087174 (National Heart, Lung, and Blood Institute). We gratefully acknowledge A. Prejusa for his assistance in the analysis of cell apoptosis.
PY - 2010/12/15
Y1 - 2010/12/15
N2 - Carcinogen-DNA adducts could lead to mutations in critical genes, eventually resulting in cancer. Many studies have shown that retinoic acid (RA) plays an important role in inducing cell apoptosis. Here we have tested the hypothesis that levels of carcinogen-DNA adducts can be diminished by DNA repair and/or by eliminating damaged cells through apoptosis. Our results showed that the levels of total DNA adducts in HepG2 cells treated with benzo(a)pyrene (BP, 2μM) + RA (1μM) were significantly reduced compared to those treated with BP only (P=0.038). In order to understand the mechanism of attenuation of DNA adducts, further experiments were performed. Cells were treated with BP (4μM) for 24 h to initiate DNA adduct formation, following which the medium containing BP was removed, and fresh medium containing 1μM RA was added. The cells were harvested 24 h after RA treatment. Interestingly, the levels of total DNA adducts were lower in the BP/RA group (390 ± 34) than those in the BP/DMSO group (544 ± 33), P=0.032. Analysis of cell apoptosis showed an increase in BP. +. RA group, compared to BP or RA only groups. Our results also indicated that attenuation of BP-DNA adducts by RA was not primarily due to its effects on CYP1A1 expression. In conclusion, our results suggest a mechanistic link between cellular apoptosis and DNA adduct formation, phenomena that play important roles in BP-mediated carcinogenesis. Furthermore, these results help understand the mechanisms of carcinogenesis, especially in relation to the chemopreventive properties of nutritional apoptosis inducers.
AB - Carcinogen-DNA adducts could lead to mutations in critical genes, eventually resulting in cancer. Many studies have shown that retinoic acid (RA) plays an important role in inducing cell apoptosis. Here we have tested the hypothesis that levels of carcinogen-DNA adducts can be diminished by DNA repair and/or by eliminating damaged cells through apoptosis. Our results showed that the levels of total DNA adducts in HepG2 cells treated with benzo(a)pyrene (BP, 2μM) + RA (1μM) were significantly reduced compared to those treated with BP only (P=0.038). In order to understand the mechanism of attenuation of DNA adducts, further experiments were performed. Cells were treated with BP (4μM) for 24 h to initiate DNA adduct formation, following which the medium containing BP was removed, and fresh medium containing 1μM RA was added. The cells were harvested 24 h after RA treatment. Interestingly, the levels of total DNA adducts were lower in the BP/RA group (390 ± 34) than those in the BP/DMSO group (544 ± 33), P=0.032. Analysis of cell apoptosis showed an increase in BP. +. RA group, compared to BP or RA only groups. Our results also indicated that attenuation of BP-DNA adducts by RA was not primarily due to its effects on CYP1A1 expression. In conclusion, our results suggest a mechanistic link between cellular apoptosis and DNA adduct formation, phenomena that play important roles in BP-mediated carcinogenesis. Furthermore, these results help understand the mechanisms of carcinogenesis, especially in relation to the chemopreventive properties of nutritional apoptosis inducers.
KW - Apoptosis
KW - Benzo(a)pyrene
KW - DNA adducts
KW - DNA repair
KW - HepG2
KW - P-Postlabeling assay
UR - http://www.scopus.com/inward/record.url?scp=78149412193&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78149412193&partnerID=8YFLogxK
U2 - 10.1016/j.taap.2010.09.019
DO - 10.1016/j.taap.2010.09.019
M3 - Article
C2 - 20888851
AN - SCOPUS:78149412193
SN - 0041-008X
VL - 249
SP - 224
EP - 230
JO - Toxicology and Applied Pharmacology
JF - Toxicology and Applied Pharmacology
IS - 3
ER -